Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Why Antares Pharma's Sliding 10% Today

TheMotleyFool

0 0

Why Antares Pharma's Sliding 10% TodayPhoto, wide shot, wide-angle lens, Pharmaceutical company, Midday, harsh overhead sunlight, directional sunlightt, photo by Art Wolfe: https://img.midjourneyapi.xyz/temp/7ae4a134-dd01-4c80-a621-18399f5a2541.png

After a big run-up in its share price following better-than-expected earnings and guidance in November, Antares Pharma (NASDAQ: ATRS) shares are down 10% at 3:30 p.m. EDT on Thursday. The company didn't report any news, so today's drop could be a simple case of profit-taking following a nearly 40% gain since October 31.

The company reported it's first quarterly operating profit in history in November, thanks to nearly triple-digit revenue growth following the launch of Xyosted -- a weekly testosterone product -- and Teva Pharmaceutical's (NYSE: TEVA) launch of a generic alternative to Mylan's EpiPen.

IMAGE SOURCE: GETTY IMAGES.

Source Fool.com

Like: 0

ATRS

Share